Objective-To assess the effects of oral vasodilator treatment on ventricular arrhythmias in acute myocardial infarction.
onset.
Design of Intervention-Double blind randomisation to 4 weeks' treatment with captopril (12.5 mg three times a day after a 6-25 mg test dose (n = 32)) or isosorbide mononitrate (20 mg three times a day (n = 31)) or placebo control (n = 37).
Outcome measures-Ventricular arrhythmic events assessed by 48 hours of Holter monitoring starting at the time of randomisation.
Results-The number of ventricular extrasystoles/hour for captopril, mononitrate, and placebo was respectively (median and range) 6 (0-162), 4 (0-38), and 10 (0-932) (2p < 0-02 mononitrate v placebo). The number of episodes of multiple extrasystoles/hour was 0-2 (0-22), 0-3 (0-4), and 0-5 (0-19); (2p < 0-02 mononitrate v placebo). Episodes of ventricular tachycardia showed a non-significant decrease in the captopril and mononitrate groups (mean (SEM) 3'2 (0.8), [2] [3] [4] (0.7), and 4*7 (1.3) for the 48 hour period). The incidence of idioventricular rhythm was also reduced in both active treatment groups (28%, 190/o, and 46% (2p < 0-05 mononitrate v placebo)).
Conclusions-Oral mononitrate (and perhaps also captopril) seems to reduce the incidence of ventricular arrhythmias in the early phase of acute myocardial infarction. The effects on life-threatening arrhythmias, such as ventricular fibrillation, and on death can only be assessed in a much larger trial. The renin-angiotensin system is activated during the first few days after acute myocardial infarction, ' 2 leading to stimulation of the heart and to increased systemic and coronary vascular resistance.3 Increases in systemic vascular resistance may increase myocardial wall stress, predisposing to infarct expansion, aneurysm, or progressive ventricular dilatation during the recovery phase after infarction. 4 5 Moreover, both in experimental models and in clinical studies, increases in wall stress have been shown to increase the frequency of ventricular arrhythmias, whereas a reduction in wall stress has the opposite effect. 6 The incidence of ventricular arrhythmias was compared by the x2 test.
Results

PATIENT CHARACTERISTICS
Baseline pre-randomisation characteristics were similar in all three groups (table 1): 84% of patients were male, the mean (SEM) age was 61 (2) years, the mean systolic blood pressure was 127 (2) mm Hg (with no patients with entry systolic pressure persistently below 100 mm Hg), and the mean heart rate was 75 (2) beats per minute (with only five patients with an entry heart rate above 100 beats per minute). Patients were randomised at a mean of 13 (1) hours from the onset of symptoms of suspected acute myocardial infarction and 85% had ST segment elevation on the initial electrocardiogram (36% in anterior leads, 47% in inferior leads alone, and 2% in both or other leads). There were slightly more patients with anterior wall infarcts in the captopril group, though this excess was not statistically significant. After randomisation, infarction was confirmed by diagnostic electrocardiographic or enzyme criteria in 98% of patients. Compliance with trial treatment during-the 48 hour period of Holter monitoring was equally good in the three groups (94%). There were no significant differences in non-trial medication between the groups, with antiplatelet therapy used in 95%, fibrinolytic therapy in 92%, intravenous nitrates in 22%, oral fi blockers in 28% and antiarrhythmic agents in 10% of patients. None of the patients received nontrial oral nitrate or converting enzyme inhibitor.
VENTRICULAR ARRHYTHMIAS
During the whole 48 hour monitoring period, ventricular extrasystoles were significantly less frequent among patients allocated to nitrate than among patients allocated to placebo ( 2 and figure 1 C). All of these episodes were non-sustained, with the one patient who had ventricular fibrillation (captopril group) being successfully defibrillated and discharged alive.
There were no significant differences in the The mechanisms by which myocardial infarction leads to arrhythmias are not, however, fully understood. Both coronary artery occlusion and reperfusion can cause myocardial excitability.'8 The adrenergic and renin-angiotensin systems are activated in acute myocardial infarction,' 2 and in experimental'9 and clinical20 studies positive correlations have been reported between high catecholamines concentrations and the occurrence of ventricular arrhythmias. This may in part be the result of activation of the renin-angiotensin system producing increases in blood pressure and in myocardial wall stress, both of which have been shown to cause arrhythmias.6 7 The overall prognostic significance of ventricular extrasystoles is unclear.2' It had been thought that extrasystoles might herald the (29) 16 (6) 7 (1)** 65 (27) 6 (0-398) 10 (0-100) 17 
